148 related articles for article (PubMed ID: 6268519)
1. Glucagon: structure-function relationships investigated by sequence deletions.
Frandsen EK; Grønvald FC; Heding LG; Johansen NL; Lundt BF; Moody AJ; Markussen J; Vølund A
Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):665-77. PubMed ID: 6268519
[TBL] [Abstract][Full Text] [Related]
2. Receptor binding and adenylate cyclase activities of glucagon analogues modified in the N-terminal region.
McKee RL; Pelton JT; Trivedi D; Johnson DG; Coy DH; Sueiras-Diaz J; Hruby VJ
Biochemistry; 1986 Apr; 25(7):1650-6. PubMed ID: 3011069
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of seven synthetic glucagon analogs, modified in position 1, 2 and/or 12, on liver and heart adenylate cyclase from rat.
Robberecht P; Waelbroeck M; Camus JC; De Neef P; Coy DH; Christophe J
Peptides; 1986; 7 Suppl 1():109-12. PubMed ID: 3018688
[TBL] [Abstract][Full Text] [Related]
4. Structure-conformation-activity studies of glucagon and semi-synthetic glucagon analogs.
Hruby VJ
Mol Cell Biochem; 1982 Apr; 44(1):49-64. PubMed ID: 6283336
[TBL] [Abstract][Full Text] [Related]
5. Structure-function relationships in glucagon. Re-evaluation of glucagon-(1-21).
Frandsen EK; Thim L; Moody AJ; Markussen J
J Biol Chem; 1985 Jun; 260(12):7581-4. PubMed ID: 2987259
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for glucagon receptor binding and activation of adenylate cyclase in liver. Study of chemically modified forms of the hormone, including N alpha-trinitrophenyl glucagon, an antagonist.
Epand RM; Rosselin G; Hoa DH; Cote TE; Laburthe M
J Biol Chem; 1981 Feb; 256(3):1128-32. PubMed ID: 6256384
[TBL] [Abstract][Full Text] [Related]
7. Topographical amino acid substitution in position 10 of glucagon leads to antagonists/partial agonists with greater binding differences.
Azizeh BY; Shenderovich MD; Trivedi D; Li G; Sturm NS; Hruby VJ
J Med Chem; 1996 Jun; 39(13):2449-55. PubMed ID: 8691441
[TBL] [Abstract][Full Text] [Related]
8. The reaction of glucagon with its receptor: evidence for discrete regions of activity and binding in the glucagon molecule.
Rodbell M; Birnbaumer L; Pohl SL; Sundby F
Proc Natl Acad Sci U S A; 1971 May; 68(5):909-13. PubMed ID: 5280527
[TBL] [Abstract][Full Text] [Related]
9. The lipid environment of the glucagon receptor regulates adenylate cyclase activity.
Houslay MD; Hesketh TR; Smith GA; Warren GB; Metcalfe JC
Biochim Biophys Acta; 1976 Jun; 436(2):495-504. PubMed ID: 179599
[TBL] [Abstract][Full Text] [Related]
10. Hormone receptors. I. Activation of rat liver plasma membrane adenylyl cyclase and fat cell lipolysis by agarose-glucagon.
Johnson CB; Blecher M; Giorgio NA
Biochem Biophys Res Commun; 1972 Feb; 46(3):1035-41. PubMed ID: 5012158
[No Abstract] [Full Text] [Related]
11. Structure-function relationships in glucagon: properties of highly purified des-His-1-, monoiodo-, and (des-Asn-28, Thr-29)(homoserine lactone-27)-glucagon.
Lin MC; Wright DE; Hruby VJ; Rodbell M
Biochemistry; 1975 Apr; 14(8):1559-63. PubMed ID: 164891
[TBL] [Abstract][Full Text] [Related]
12. Glucagon structure-function relationships using isolated rat hepatocytes.
Hruby VJ; Agarwal NS; Griffen A; Bregman MD; Nugent CA; Brendel K
Biochim Biophys Acta; 1981 May; 674(3):383-90. PubMed ID: 7236736
[TBL] [Abstract][Full Text] [Related]
13. The role of nonspecific hydrophobic interactions in the biological activity of N epsilon-acyl derivatives of glucagon. Studies of conformation, receptor binding, and adenylate cyclase activation.
Carrey EA; Epand RM
J Biol Chem; 1982 Sep; 257(18):10624-30. PubMed ID: 6286664
[TBL] [Abstract][Full Text] [Related]
14. Synthetic peptide antagonists of glucagon.
Unson CG; Andreu D; Gurzenda EM; Merrifield RB
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4083-7. PubMed ID: 3035568
[TBL] [Abstract][Full Text] [Related]
15. The effect of vinblastine on the glucagon, basal and GTP-stimulated states of the adenylate cyclase from rat liver plasma membranes.
Whetton AD; Houslay MD
FEBS Lett; 1980 Mar; 111(2):290-4. PubMed ID: 6244186
[No Abstract] [Full Text] [Related]
16. The role of phenylalanine at position 6 in glucagon's mechanism of biological action: multiple replacement analogues of glucagon.
Azizeh BY; Ahn JM; Caspari R; Shenderovich MD; Trivedi D; Hruby VJ
J Med Chem; 1997 Aug; 40(16):2555-62. PubMed ID: 9258362
[TBL] [Abstract][Full Text] [Related]
17. Pure glucagon antagonists: biological activities and cAMP accumulation using phosphodiesterase inhibitors.
Azizeh BY; Van Tine BA; Trivedi D; Hruby VJ
Peptides; 1997; 18(5):633-41. PubMed ID: 9213355
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of glucagon activation of adenylate cyclase in the presence of Mn2+.
Houslay MD; Heyworth CM; Whetton AD
FEBS Lett; 1983 May; 155(2):311-6. PubMed ID: 6303847
[TBL] [Abstract][Full Text] [Related]
19. Effect of specific trinitrophenylation of the lysine epsilon amino group of glucagon on receptor binding and adenylate cyclase activation.
Liepnieks JJ; Epand RM
Arch Biochem Biophys; 1983 Aug; 225(1):102-9. PubMed ID: 6311099
[TBL] [Abstract][Full Text] [Related]
20. The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it.
Houslay MD; Metcalfe JC; Warren GB; Hesketh TR; Smith GA
Biochim Biophys Acta; 1976 Jun; 436(2):489-94. PubMed ID: 179598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
